Risk-Takers Will Like Corcept Therapeutics Inc (NASDAQ: CORT).

In today’s recent session, 0.73 million shares of the Corcept Therapeutics Inc (NASDAQ:CORT) have been traded, and its beta is 0.17. Most recently the company’s share price was $71.61, and it changed around -$2.33 or -3.15% from the last close, which brings the market valuation of the company to $7.59B. CORT at last check was trading at a discount to its 52-week high of $117.33, offering almost -63.85% off that amount. The share price’s 52-week low was $23.02, which indicates that the recent value has risen by an impressive 67.85% since then.

Corcept Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended CORT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.

Corcept Therapeutics Inc (NASDAQ:CORT) trade information

Instantly CORT has been showing red trend so far today with a performance of -3.15% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 75.25 on recent trading dayincreased the stock’s daily price by 4.84%. The company’s shares are currently up 42.11% year-to-date, but still down -2.21% over the last five days. On the other hand, Corcept Therapeutics Inc (NASDAQ:CORT) is -3.81% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $145, which translates to bulls needing to increase their stock price by 50.61% from its current value. Analyst projections state that CORT is forecast to be at a low of $145 and a high of $145.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 9.89%. Corcept Therapeutics Inc earnings are expected to increase by 11.99% in 2025, but the outlook is positive 69.47% per year for the next five years.

CORT Dividends

Corcept Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-04.

VANGUARD GROUP INC, with 9.2648% or 9.55 million shares worth $310.4 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 5.77 shares worth $410.88 million, making up 5.44% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 2.8 shares worth around $199.84 million, which represents about 2.64% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.